Earlier quoted context omitted.
You have to choose a system. If we don't want naturally-occurring compounds patented, but we want them researched for potential drug use, we need more public funding. Otherwise, we have to offer researchers and drug manufacturers an incentive to take risks with exploring these compounds. Barring lugdunin from being patented while providing no public funding would incentivise this group to withhold publication until t…
These are German researchers at a German university. Aren't they already publicly funded? (honest question, I don't know).
Nasal Bacteria Pump Out a Potential New Antibiotic That Kills MRSA
41–50 of 98 posts
Re: Nasal Bacteria Pump Out a Potential New Antibiotic That Kills MRSA
#42Earlier quoted context omitted.
These are German researchers at a German university. Aren't they already publicly funded? (honest question, I don't know).
I don't know but it wouldn't make a difference as long as someone else could come along and take out a patent on what they found. This is the sort of thing that requires and international treaty.
Unfortunately many universities (and hence researchers) are under pressure to commercialise their IP, based on the assumption that such behaviour is beneficial to the economy.
Re: Nasal Bacteria Pump Out a Potential New Antibiotic That Kills MRSA
#43Awesome research. But... > The researchers then checked snot from hospitalized patients. Of 187 samples, all but one were colonized by either S. aureus or S. lugdunensis > S. lugdunensis, was killing S. aureus. Its weapon of choice? A small compound dubbed lugdunin > The German researchers who performed the study have filed a patent for lugdunin Are we really allowing people to patent naturally occurring biological c…
You have to choose a system. If we don't want naturally-occurring compounds patented, but we want them researched for potential drug use, we need more public funding. Otherwise, we have to offer researchers and drug manufacturers an incentive to take risks with exploring these compounds. Barring lugdunin from being patented while providing no public funding would incentivise this group to withhold publication until t…
Its not a "choose a system" kind of deal. It never has been. It always been state funded research + investment supported by patents + university funds + non-profit funds + additional government funded incentives. The question we should ask is if this specific incentive is needed together with all the other incentives in order to create a end user product that will saves lives sometime in the future.
Re: Nasal Bacteria Pump Out a Potential New Antibiotic That Kills MRSA
#44Earlier quoted context omitted.
You have to choose a system. If we don't want naturally-occurring compounds patented, but we want them researched for potential drug use, we need more public funding. Otherwise, we have to offer researchers and drug manufacturers an incentive to take risks with exploring these compounds. Barring lugdunin from being patented while providing no public funding would incentivise this group to withhold publication until t…
It sounds like drug discovery ought to be taxpayer-funded, then, as a project that is in the public interest but difficult to monetize without jeopardizing the public interest.
Worst is when American companies charge U.S. customers higher prices than overseas consumers for drugs that were developed using USA-taxpayer-funded research.
Re: Nasal Bacteria Pump Out a Potential New Antibiotic That Kills MRSA
#45Earlier quoted context omitted.
You have to choose a system. If we don't want naturally-occurring compounds patented, but we want them researched for potential drug use, we need more public funding. Otherwise, we have to offer researchers and drug manufacturers an incentive to take risks with exploring these compounds. Barring lugdunin from being patented while providing no public funding would incentivise this group to withhold publication until t…
>You have to choose a system. Cool I choose heaps of public funding and patents dead forever!
Re: Nasal Bacteria Pump Out a Potential New Antibiotic That Kills MRSA
#46Earlier quoted context omitted.
Are you sure about that? I would think that the patent wouldn't apply to non-commercial investigations or research. That is you would be free to synthesize or extract this chemical in a laboratory environment. However, if you wished to manufacture the drug for commercial purposes then you would need to license the patent.
You're right that it won't apply for non-commercial investigations. But how are you funding the investigation? It's typically funded by the proceeds generated from the research. Research is always hit and miss as to profitability, more miss than hit. Factor in potentially unknown licensing arrangements, even if you do have a "hit", and suddenly your research doesn't look like such a good idea.
That's only true in the case of commercial R&D. For non-commercial (academic) research, the funding is normally through a grant mechanism (not company supported). Academic research is almost never concerned with the licensing/patent issues aside from "can I run my experiment". It is common for academic labs to use drugs that are still "in the pipeline" for experiments.
Re: Nasal Bacteria Pump Out a Potential New Antibiotic That Kills MRSA
#47Wont using this be long term harmful to our nasal health, as bacteria acquire immunity?
Re: Nasal Bacteria Pump Out a Potential New Antibiotic That Kills MRSA
#48Re: Nasal Bacteria Pump Out a Potential New Antibiotic That Kills MRSA
#49Partly relevant: a few months ago they discovered bacteria in beards that also kill MRSA: http://www.independent.co.uk/news/science/beards-good-for-he...
Interesting read. What I don't understand is why other body hair is not mentioned, and if that has the same effect. If not, what makes a beard different?